《2025年中国双舱益生菌及临床益生菌行业研究报告》涵盖双舱益生菌和临床益生菌两大板块，系统梳理了益生菌行业的定义分类、政策标准、发展历程、市场规模、创新趋势及未来发展前景等。
中国的益生菌市场经历了研究起步与微生态学发展、政策规范与市场培育等阶段，目前已进入国际化与创新驱动的新的发展阶段，已形成千亿级市场规模。得益于公众健康意识提升、企业研发投入增加等驱动，中国益生菌及临床益生菌市场规模持续增长，其中，临床益生菌以医院与零售药店为核心渠道，未来行业将朝着专业化、精细化方向深度演进。
从产品创新来看，粉液双舱益生菌作为创新剂型，以固液分舱设计将上层菌粉与下层液态益生元分舱储存以保持活性。使用时一键按压完成混合，即时激活菌体后即可饮用。该设计让益生菌在储存期间不失活，同时添加了高活性菌株，实现鲜活特性。粉液双舱益生菌具备较大市场潜力与商业化空间，助力行业技术水平提升及高附加值产品形成。
The White Paper on 2025 China’s Probiotics Market focuses on two key areas, dual-chamber probiotics and clinical probiotics. It summarizes the definition and classification of probiotics, relevant policies and standards, industry development, market size, innovation trends and the future growth.
China’s probiotics market has gone through stages including early research and microbiome development, regulatory refinement and market cultivation. It has now entered a new phase driven by innovation and international expansion, forming a market of significant scale. With rising public health awareness and increasing R&D investment from enterprises, the market for both general probiotics and clinical probiotics continues to grow. Clinical probiotics are mainly distributed through hospitals and retail pharmacies, and is expected to develop further toward specialization and precision.
From a product innovation perspective, dual-chamber probiotics have emerged as a new format of probiotics products. The powder and liquid are stored separately to maintain probiotic viability, and consumers activate the product by pressing the cap to mix the two parts before drinking. This design helps prevent loss of activity during storage and allows the use of high-activity strains for a fresher product experience. With relatively high market potential and commercial value, dual-chamber probiotics are expected to support industry upgrades and the development of higher value-added products.
